Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05269472 · ClinicalTrials.gov registry record
Trigeminal Neuralgia Electrophysiology
A clinical trial of Trigeminal Neuralgia, sponsored by University of Minnesota.
- Recruiting
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT05269472: Recruiting study of Trigeminal Neuralgia, sponsored by University of Minnesota.
NCT05269472 is a study of Trigeminal Neuralgia that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 30 participants, below the 5,766-participant average among 9 other Trigeminal Neuralgia trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05269472, a study of Trigeminal Neuralgia, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The study intervention is to perform standard somatosensory evoked responses limited to the face during rhizotomy procedures of the gasserian ganglion (trigeminal ganglion) for the treatment of trigeminal neuralgia. The evoked responses will be measured at two locations before and after the clinical rhizotomy including: the standard contralateral scalp (EEG) and at the gasserian ganglion through an FDA-approved recording electrode.
Primary Outcome
percentage of consented participants who complete the study
Conditions Studied
Interventions
- PROCEDURE Trigeminal Electrophysiology
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2022-04-04 |
| Est. Completion | 2027-04-07 |
What NCT05269472 shows while recruiting
NCT05269472 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 5,766-participant average among 9 other Trigeminal Neuralgia trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Trigeminal Neuralgia appearing as the primary indexed condition, and to 1 intervention - of which Trigeminal Electrophysiology is the first listed.
NCT05269472 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT05269472 about?
NCT05269472 is a clinical study titled "Trigeminal Neuralgia Electrophysiology". The study intervention is to perform standard somatosensory evoked responses limited to the face during rhizotomy procedures of the gasserian ganglion (trigeminal ganglion) for the treatment of trigeminal neuralgia. The evoked responses will be measured at two locations before and after the clinical...
What is the current status of trial NCT05269472?
This trial is currently recruiting. The enrollment target is 30 participants. The study started on 2022-04-04. Estimated completion is 2027-04-07.
What conditions does trial NCT05269472 study?
This clinical trial studies the following conditions: Trigeminal Neuralgia.
What interventions are being tested in trial NCT05269472?
The interventions under investigation include: Trigeminal Electrophysiology (PROCEDURE).
Who is sponsoring clinical trial NCT05269472?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05269472 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trigeminal Neuralgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05269472's enrollment target sits among peer trials
30 7th of 9 higher than 2 of 9 other Trigeminal Neuralgia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Trigeminal Neuralgia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Will Erwin Headache Research Center - Cluster Headache Study
RECRUITING
-
OnabotulinumtoxinA for Trigeminal Neuralgia
RECRUITING · Phase 4
-
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
RECRUITING
-
Trigeminal Evoked Responses to Improve Rhizotomy
RECRUITING · Early Phase 1
-
RAD 1501: A Trial of Virtual Cone Trigeminal Neuralgia Radiosurgery
ACTIVE NOT RECRUITING · NA
-
Transcranial Magnetic Stimulation for Chronic Neuropathic Pain
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI